SEC Form 4 · accession 0001093557-16-000695
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew K Balo
Officer — EVP, Clinical and Regulatory
Period of report
Sep 9, 2016
Accepted (ET)
Sep 13, 2016 · 8:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 9, 2016 | D | 4,445 | $93.7226 | D | 125,565 | D | |
| Common StockF1,F2 | Sep 9, 2016 | D | 4,223 | $93.7226 | D | 121,342 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
- F2Included in this number are 70,084 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 23,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 8,334 of which were granted on March 8, 2014 and shall vest through March 8, 2017.